View Document Preview and Link Document Date: 2014-12-05 11:30:09 Open Document File Size: 247,07 KB Share Result on Facebook
City Cambridge / / Company Celgene Corporation / Media Relations Dan Budwick Pure Communications Inc. / M.D. / Business Development & Alliance Management / Paris Investor Relations Matt Clawson Pure Communications Inc. / / Country Thailand / France / United States / Australia / / / Event FDA Phase / Business Partnership / / Facility Baylor College of Medicine / INDUSTRY LEADING PIPELINE / / IndustryTerm transformational products / orphan disease products / gene-modified products / gene therapy technologies / generation product / treatment of sickle cell disease / gene therapy products / / MedicalCondition lymphocytic leukemia / Initiated Sickle Cell Disease / solid tumors / lethal neurological disorder / additional beta-thalassemia / severe anemia / Beta-thalassemia / address sickle cell disease / orphan diseases / lymphoblastic leukemia / cancer / disease / Chronic / Hemophilia B / hematologic malignancies / CHILDHOOD CEREBR AL ADRENOLEUKODYSTROPHY / Childhood Cerebral Adrenoleukodystrophy / chronic blood transfusion regimens / Retinal disease / beta-thalassemia major / chronic anemia / Adrenoleukodystrophy / severe sickle cell disease / inherited monogenic disease / sickle cell disease / specific cancer / severe genetic diseases / vegetative state / Cell Disease / numerous diseases / inherited blood disorder / / MedicalTreatment blood transfusion / gene therapy / / Organization European Medicines Agency / Baylor College of Medicine / U.S. Food and Drug Administration / / Person David M. Davidson / James M. DeTore / Nick Leschly / Mitchell H. Finer / Jeffrey T. Walsh / Cyrus Mozayeni / Jason F. Cole / / / Position Chief Financial Officer / Vice President / Vice President / General Counsel / Chief Scientific Officer / Chief Operating Officer / Chief Medical Officer / Chief / / Product hydroxyurea / HGB-206 / HGB-205 / France / Lenti-D / Hematologic Diseases LentiGlobin® Worldwide CAR T / / ProvinceOrState Massachusetts / / Technology transplantation / stem cells / Gene Therapy / gene therapy technologies / / URL www.bluebirdbio.com / / SocialTag 
JUNE[removed]NASDAQ: BLUE Transforming the Lives of Patients